PTPRC and neoplasm: The Hf12-DBA with antibody group showed significant increase of tumor-infiltrating B cells (Supplementary Fig. 29) as well as CD45+ leukocyte cells (Fig. 6b) in the primary tumors but not in the distant tumors.